Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2020

Open Access 01-12-2020 | Update

First-line support for assistance in breathing in children: statistical and health economic analysis plan for the FIRST-ABC trial

Authors: Izabella Orzechowska, M. Zia Sadique, Karen Thomas, Peter Davis, Kevin P. Morris, Paul R. Mouncey, Mark J. Peters, Alvin Richards-Belle, Lyvonne N. Tume, Padmanabhan Ramnarayan, David A. Harrison

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

The FIRST-ABC trial comprises of two pragmatic, multicentre, parallel groups, non-inferiority randomised clinical trials designed to evaluate the clinical non-inferiority of first-line use of high flow nasal cannula (HFNC) to continuous positive airway pressure (CPAP) in critically ill children who require non-invasive respiratory support (NRS).

Objectives

To describe the pre-specified statistical and health economic analysis for the FIRST-ABC trial before completion of patient recruitment and data collection.

Methods

The statistical analysis plan was designed by the chief investigators and statisticians. We define the primary and secondary outcomes, summarise methods for data collection and safety monitoring, and present a detailed description of the planned statistical and health economic analysis.

Results

The primary clinical outcome is time to liberation from respiratory support. The primary effect estimate will be the adjusted hazard ratio, reported with a 95% confidence interval. As a sensitivity analysis, the primary analysis will be repeated using time to start weaning of NRS. Subgroup analyses will be performed to test for interactions between the effect of allocated treatment group and pre-specified baseline covariates. The health economic analysis will follow the intention-to-treat principle and report the mean (95% confidence interval) incremental costs, quality-adjusted life years (QALYs) and cost-effectiveness up to 6 months. All analyses will be performed separately for each of the two trials, and any results will not be combined.

Conclusion

The FIRST-ABC trial will assess the non-inferiority of HFNC compared to CPAP in two parallel trials with shared infrastructure (step-up RCT and step-down RCT). We have developed a pre-specified statistical and health economics analysis plan for the FIRST-ABC study before trial completion to minimise analytical bias.

Trial registration

ISRCTN ISRCTN60048867. Registered on 19 June 2019.
Literature
1.
Paediatric Intensive Care Network (PICANet). National report of the Paediatric Intensive Care Audit Network, January 2014 - December 2016. Leeds: Universities of Leeds and Leicester; 2017.
2.
Wolfler A, Calderini E, Iannella E, et al. Evolution of noninvasive mechanical ventilation use: a cohort study among Italian PICUs. Pediatr Crit Care Med. 2015;16(5):418–27.CrossRefPubMed
3.
Lee JH, Rehder KJ, Williford L, et al. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Med. 2013;39(2):247–57.CrossRefPubMed
4.
Spentzas T, Minarik M, Patters AB, et al. Children with respiratory distress treated with high-flow nasal cannula. J Intensive Care Med. 2009;24(5):323–8.CrossRefPubMed
5.
Ramnarayan P, Schibler A. Glass half empty or half full? The story of high-flow nasal cannula therapy in critically ill children. Intensive Care Med. 2017;43(2):246–9.CrossRefPubMed
6.
Morris JV, Kapetanstrataki M, Parslow RC, et al. Patterns of use of heated humidified high-flow nasal cannula therapy in PICUs in the United Kingdom and Republic of Ireland*. Pediatr Crit Care Med. 2019;20(3):223–32.CrossRefPubMed
7.
Gamble C, Krishan A, Stocken D, et al. Guidelines for the content of statistical analysis plans in clinical trials. JAMA. 2017;318(23):2337–43.CrossRefPubMed
8.
Ramnarayan P, Lister P, Dominguez T, et al. FIRST-line support for Assistance in Breathing in Children (FIRST-ABC): a multicentre pilot randomised controlled trial of high-flow nasal cannula therapy versus continuous positive airway pressure in paediatric critical care. Crit Care. 2018;22(1):144.CrossRefPubMedPubMedCentral
9.
Carter MC, Miles MS. The parental stressor scale: pediatric intensive care unit. Matern Child Nurs J. 1989;18(3):187–98.PubMed
10.
Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37:126–39.CrossRefPubMed
11.
12.
Wang R, Lagakos SW, Ware JH, et al. Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357:2189–94.CrossRefPubMed
13.
Sun X, Ioannidis JP, Agoritsas T, et al. How to use a subgroup analysis: users’ guide to the medical literature. JAMA. 2014;311:405–11.CrossRefPubMed
14.
Richards-Belle A, Davis P, Drikite L, et al. FIRST-line support for assistance in breathing in children (FIRST-ABC): a master protocol of two randomised trials to evaluate the non-inferiority of high-flow nasal cannula (HFNC) versus continuous positive airway pressure (CPAP) for non-invasive respiratory support in paediatric critical care. BMJ Open. 2020;10:e038002.
15.
16.
van Dijk M, Peters JWB, van Deventer P, et al. The comfort behavior scale: a tool for assessing pain and sedation in infants. Am J Nurs. 2005;105:33–6.CrossRefPubMed
17.
Gomes M, Ng ES-W, Grieve R, et al. Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials. Med Decis Mak. 2012;32:350–36.CrossRef
18.
Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 2004.
19.
Lambe T, Frew E, Ives NJ, Woolley RL, Cummins C, Brettell EA, et al. Mapping the Paediatric Quality of Life Inventory (PedsQL) generic core scales onto the Child Health Utility Index-9 Dimension (CHU-9D) score for economic evaluation in children. Pharmacoeconomics. 2018;36(4):451–65.CrossRefPubMed
Metadata
Title
First-line support for assistance in breathing in children: statistical and health economic analysis plan for the FIRST-ABC trial
Authors
Izabella Orzechowska
M. Zia Sadique
Karen Thomas
Peter Davis
Kevin P. Morris
Paul R. Mouncey
Mark J. Peters
Alvin Richards-Belle
Lyvonne N. Tume
Padmanabhan Ramnarayan
David A. Harrison
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-020-04818-w

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue

Correction

Correction to: Protocol for a randomised controlled trial to investigate the effect of home- and gym-based resistance exercise training on glycaemic control, body composition and muscle strength

Research

Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III

Study protocol

Evaluating a multicomponent program to improve hypertension control in Guatemala: study protocol for an effectiveness-implementation cluster randomized trial

Study protocol

Jakyakgamcho-tang in the relief of delayed-onset muscle soreness in healthy adults: study protocol for a randomized, double-blind, placebo-controlled, crossover design clinical trial

Study protocol

Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study

Research

Does a video clip enhance recruitment into a parenting trial? Learnings from a study within a trial